HIGHLIGHTS
- who: Report and colleagues from the Wisconsin, Milwaukee, USA have published the research: A Carcinoma of Unknown Primary (CUP) Patient Treated Successfully With Immunotherapy Upon Recognition of Deficient Mismatch Repair Signature on Liquid Biopsy: A Case Report, in the Journal: Cureus of July/23,/2022
- what: This case report highlights that ICIs can be successfully utilized in the treatment of patients with CUP harboring MSI-H signature.
SUMMARY
Carcinoma of unknown primary (CUP) is a heterogeneous group of metastatic cancer in which the origin of the . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.